Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of two doses of Keppra XR
compared with a historical control as the placebo, in the monotherapy treatment of partial
onset seizures.